Wednesday, Jan 31, 2024 · SEC filings

What the smart money revealed on Jan 31

Real insider buys41insiders · $24.4M
Real insider sales61insiders · $89M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

535 insider filings came in. We hid 51 planned (10b5-1) sellers and 357 people whose filings were routine, like grants and tax withholding.

group

4 insiders at Akoustis Technologies (AKTS) bought $750K of stock

Roles: CEO, CFO, Executive VP, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 29
$750K
group

3 insiders at CG Oncology (CGON) bought $5.06M of stock

Roles: CFO, Chief Medical Officer, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 29
$5.06M
group

3 insiders at Relmada Therapeutics (RLMD) bought $663K of stock

Roles: CEO, CFO, CA and CO. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 29–31
$663K
trending_up

ArriVent Biopharma (AVBP) Director James Healy bought $8M

444,444 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 30
$8M
trending_up

ArriVent Biopharma (AVBP) Director Carl Gordon bought $4M

222,222 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 3 beat Traded Jan 30
$4M
trending_up

Tourmaline Bio (TRML) Director Mark McDade bought $3.25M

100,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 29
$3.25M
trending_up

Epsilon Energy (EPSN) CEO Jason Stabell bought $1.18M

245,200 shares on the open market. Not a grant or an option exercise. Their past buys: 6 of 7 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 6 of 7 beat Traded Jan 30
$1.18M
trending_down

DraftKings (DKNG) President Paul Liberman sold $20.4M

Not marked as a planned 10b5-1 sale. Sold 18% of the shares they held directly. Still holds 2.29M shares.

Real sale Form 4 Traded Jan 29
$20.4M
trending_down

Palo Alto Networks (PANW) EVP Lee Klarich sold $15.4M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 198,105 shares directly.

Real sale Form 4 Traded Jan 29
$15.4M
trending_down

ServiceNow (NOW) Chief Commercial Officer Paul Smith sold $1.4M

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jan 30
$1.4M
Show 27 more real buys
Hamilton Lane Private Assets Fund · Director Timothy Galbraith · Traded Jan 31
$530K
TBBK Bancorp · Director Daniela Mielke · Traded Jan 31
$150K
COLB Columbia Banking System · Senior Executive VP Christopher Merrywell · Traded Jan 30
$105K
WBA Walgreens Boots Alliance · Director Valerie Jarrett · Traded Jan 29
$100K
MBLY Mobileye Global · Director Patrick Gelsinger · Traded Jan 29
$99.9K
PFBX Peoples Financial · CEO/President Chevis Swetman · Traded Jan 31
$81.6K
BHRB Burke & Herbert Financial Services · Director Shawn McLaughlin · Traded Jan 31
$60.2K
BHRB Burke & Herbert Financial Services · Director Jose Riojas · Traded Jan 31
$52.4K
HNVR Hanover Bancorp · Director Elena Sisti · Traded Jan 29
$49.5K
COLB Columbia Banking System · Director Craig Eerkes · Traded Jan 30
$44.6K
ISBA Isabella Bank · Director Richard McGuirk · Traded Jan 29
$30K
PCSA Processa Pharmaceuticals · CEO George Ng · Traded Jan 30
$27K
RELL Richardson Electronics · Director Kenneth Halverson · Traded Jan 29
$25.2K
PCSA Processa Pharmaceuticals · Director Justin Yorke · Traded Jan 30
$21.5K
ISBA Isabella Bank · Director Gregory Varner · Traded Jan 29
$20K
CNXC Concentrix · EVP Jane Fogarty · Traded Jan 30
$17.9K
ISBA Isabella Bank · Director Sarah Opperman · Traded Jan 29
$13.8K
ISBA Isabella Bank · Director Jill Bourland · Traded Jan 29
$12K
ISBA Isabella Bank · Director Chad Payton · Traded Jan 29
$11K
FMNB Farmers National Banc · Director Gina Richardson · Traded Jan 30
$10.4K
ISBA Isabella Bank · Director Jae Evans · Traded Jan 29
$9.98K
FBIZ First Business Financial Services · Director Carol Sanders · Traded Jan 30
$5.99K
MPB Mid Penn Bancorp · Director Frank Gumina Jr. · Traded Jan 30
$4.61K
KWY Kingsway Financial Services · President and CEO John Fitzgerald · Traded Jan 30
$2.51K
KWY Kingsway Financial Services · CFO and EVP Kent Hansen · Traded Jan 30
$1.57K
WBHC Wilson Bank Holding · Director Herbert Richerson · Traded Jan 31
$1.29K
RCG RENN Fund · President and CEO Murray Stahl · Traded Jan 30
$91
Show 58 more real sales
AXP American Express · Pres. Denise Pickett · Traded Jan 30
$9.57M
PCAR Paccar · Executive Chairman Mark Pigott · Traded Jan 30
$7.58M
JBL Jabil · Director David Stout · Traded Jan 29
$3.85M
BBT Berkshire Hills Bancorp · Director Michael Zaitzeff · Traded Jan 29–31
$2.84M
MSM MSC Industrial Direct · Director Mitchell Jacobson · Traded Jan 31
$2.43M
EPSN Epsilon Energy · Director John Lovoi · Traded Jan 30
$2.41M
GATX GATX · EVP and CFO Thomas Ellman · Traded Jan 30
$2.3M
TRV Travelers Companies · EVP Maria Olivo · Traded Jan 30
$2.25M
TEAM Atlassian · Co-CEO Michael Cannon-Brookes · Traded Jan 30
$2.12M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Jan 30
$2.12M
LKFN Lakeland Financial · Director Michael Kubacki · Traded Jan 30
$1.9M
PAYX Paychex · Sr. VP of Sales Mark Bottini · Traded Jan 29
$1.87M
AXP American Express · President Howard Grosfield · Traded Jan 30
$1.43M
COUR Coursera · President and CEO Jeffrey Maggioncalda · Traded Jan 29
$1M
AGYS Agilysys · CFO William Wood III · Traded Jan 29
$854K
WSFS WSFS Financial · Executive Vice President Arthur Bacci · Traded Jan 29
$748K
EXP Eagle Materials · EVP and General Counsel Matt Newby · Traded Jan 29
$708K
NOW ServiceNow · Chief People Officer Jacqueline Canney · Traded Jan 29
$650K
WBS Webster Financial · President Christopher Motl · Traded Jan 30
$549K
TRV Travelers Companies · Vice Chairman William Heyman · Traded Jan 30
$534K
GIS General Mills · Group President Jonathon Nudi · Traded Jan 29
$492K
SMCI Super Micro Computer · President and CEO Charles Liang · Traded Jan 29
$458K
LBRT Liberty Energy · Chief Legal Officer R. Sean Elliott · Traded Jan 30
$410K
BWB Bridgewater Bancshares · President and CEO Jerry Baack · Traded Jan 30–31
$394K
CATY Cathay General Bancorp · Vice Chairman Anthony Tang · Traded Jan 29
$304K
KURA Kura Oncology · Chief Medical Officer Stephen Dale · Traded Jan 29–30
$231K
RJF Raymond James Financial · EVP Jonathan Santelli · Traded Jan 29
$212K
PKBK Parke Bancorp · Director Jeffrey Kripitz · Traded Jan 29–30
$194K
TER Teradyne · President Richard Burns · Traded Jan 30
$183K
APLS Apellis Pharmaceuticals · CEO Cedric Francois · Traded Jan 29
$182K
SDIG Stronghold Digital Mining · CFO Matthew Smith · Traded Jan 30
$97.7K
PFS Provident Financial Services · Director Robert McNerney · Traded Jan 30
$89.3K
CMA Comerica · EVP Cassandra McKinney · Traded Jan 29
$88.3K
APLS Apellis Pharmaceuticals · Chief Commercial Officer Adam Townsend · Traded Jan 29
$58.1K
APLS Apellis Pharmaceuticals · CFO Timothy Sullivan · Traded Jan 29
$58.1K
APLS Apellis Pharmaceuticals · General Counsel David Watson · Traded Jan 29
$58.1K
WTFC Wintrust Financial · Evp-controller and Chief ACC OFF Jeffrey Hahnfeld · Traded Jan 31
$57.6K
FMNB Farmers National Banc · Sevp Timothy Shaffer · Traded Jan 29
$56.9K
APLS Apellis Pharmaceuticals · Chief Scientific Officer Pascal Deschatelets · Traded Jan 29
$56.1K
APLS Apellis Pharmaceuticals · Chief Technical Officer Nur Nicholson · Traded Jan 29
$53.6K
KURA Kura Oncology · SVP Thomas Doyle · Traded Jan 29
$41.3K
UNTY Unity Bancorp · Director Mary Gross · Traded Jan 29
$40.3K
KURA Kura Oncology · Chief Legal Officer Teresa Bair · Traded Jan 29
$36.5K
RLAY Relay Therapeutics · President Donald Bergstrom · Traded Jan 29
$30.6K
KURA Kura Oncology · COO Kathleen Ford · Traded Jan 29
$26.6K
APLS Apellis Pharmaceuticals · Chief Business and Strat Officer Mark DeLong · Traded Jan 29
$23.5K
RLAY Relay Therapeutics · CFO Thomas Catinazzo · Traded Jan 29
$19.3K
RLAY Relay Therapeutics · Chief Legal Officer Brian Adams · Traded Jan 29
$18.6K
URG Ur-Energy · Director James Franklin · Traded Jan 30
$18.3K
RLAY Relay Therapeutics · Chief Corporate Development Officer Peter Rahmer · Traded Jan 29
$15.9K
UBX Unity Biotechnology · CEO Anirvan Ghosh · Traded Jan 30
$2.02K
PSNL Personalis · CFO and COO Aaron Tachibana · Traded Jan 29
$981
PSNL Personalis · Chief Medical Officer and EVP Richard Chen · Traded Jan 29
$721
PXMD PaxMedica · Director Zachary Rome · Traded Jan 29
$389
SDIG Stronghold Digital Mining · Senior Vice President Richard Shaffer · Traded Jan 29
$213
PXMD PaxMedica · CEO Howard Weisman · Traded Jan 29
$175
PXMD PaxMedica · Director Karen LaRochelle · Traded Jan 29
$37
PXMD PaxMedica · Director John Coelho · Traded Jan 29
$13

13F season

Holdings as of Dec 31, 2023 are due Feb 14

49 funds have filed so far. 40 filed for the quarter before.

Biggest real insider buys, Jan 25–31

Open-market buys by officers and directors, filed in the 7 days up to Jan 31.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist